Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
Display Omitted
Autor*in: |
Coppolino, Giuseppe [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
Alogliptin (PubChem CID: 11450633) Linagliptin (PubChem CID: 10096344) Sitagliptin (PubChem CID: 4369359) Saxagliptin (PubChem CID: 11243969) |
---|
Umfang: |
21 |
---|
Übergeordnetes Werk: |
Enthalten in: Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China - Deng, Lixing ELSEVIER, 2022, the official journal of the Italian Pharmacological Society, London |
---|---|
Übergeordnetes Werk: |
volume:129 ; year:2018 ; pages:274-294 ; extent:21 |
Links: |
---|
DOI / URN: |
10.1016/j.phrs.2017.12.001 |
---|
Katalog-ID: |
ELV042066786 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV042066786 | ||
003 | DE-627 | ||
005 | 20230624093500.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180726s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.phrs.2017.12.001 |2 doi | |
028 | 5 | 2 | |a GBV00000000000144A.pica |
035 | |a (DE-627)ELV042066786 | ||
035 | |a (ELSEVIER)S1043-6618(17)30860-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 330 |q VZ |
100 | 1 | |a Coppolino, Giuseppe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
264 | 1 | |c 2018 | |
300 | |a 21 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Display Omitted | ||
650 | 7 | |a Alogliptin (PubChem CID: 11450633) |2 Elsevier | |
650 | 7 | |a Linagliptin (PubChem CID: 10096344) |2 Elsevier | |
650 | 7 | |a Sitagliptin (PubChem CID: 4369359) |2 Elsevier | |
650 | 7 | |a Saxagliptin (PubChem CID: 11243969) |2 Elsevier | |
650 | 7 | |a Glucagon-like peptide-1 (PubChem CID: 16135499) |2 Elsevier | |
650 | 7 | |a Vildagliptin (PubChem CID: 6918537) |2 Elsevier | |
700 | 1 | |a Leporini, Christian |4 oth | |
700 | 1 | |a Rivoli, Laura |4 oth | |
700 | 1 | |a Ursini, Francesco |4 oth | |
700 | 1 | |a di Paola, Eugenio Donato |4 oth | |
700 | 1 | |a Cernaro, Valeria |4 oth | |
700 | 1 | |a Arturi, Franco |4 oth | |
700 | 1 | |a Bolignano, Davide |4 oth | |
700 | 1 | |a Russo, Emilio |4 oth | |
700 | 1 | |a De Sarro, Giovambattista |4 oth | |
700 | 1 | |a Andreucci, Michele |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Academic Press |a Deng, Lixing ELSEVIER |t Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |d 2022 |d the official journal of the Italian Pharmacological Society |g London |w (DE-627)ELV008224951 |
773 | 1 | 8 | |g volume:129 |g year:2018 |g pages:274-294 |g extent:21 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2017.12.001 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
951 | |a AR | ||
952 | |d 129 |j 2018 |h 274-294 |g 21 | ||
953 | |2 045F |a 610 |
author_variant |
g c gc |
---|---|
matchkey_str |
coppolinogiuseppeleporinichristianrivoli:2018----:xlrntefetodpihbtroteinyrmhb |
hierarchy_sort_str |
2018 |
publishDate |
2018 |
allfields |
10.1016/j.phrs.2017.12.001 doi GBV00000000000144A.pica (DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Coppolino, Giuseppe verfasserin aut Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 2018 21 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier Leporini, Christian oth Rivoli, Laura oth Ursini, Francesco oth di Paola, Eugenio Donato oth Cernaro, Valeria oth Arturi, Franco oth Bolignano, Davide oth Russo, Emilio oth De Sarro, Giovambattista oth Andreucci, Michele oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:129 year:2018 pages:274-294 extent:21 https://doi.org/10.1016/j.phrs.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 129 2018 274-294 21 045F 610 |
spelling |
10.1016/j.phrs.2017.12.001 doi GBV00000000000144A.pica (DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Coppolino, Giuseppe verfasserin aut Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 2018 21 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier Leporini, Christian oth Rivoli, Laura oth Ursini, Francesco oth di Paola, Eugenio Donato oth Cernaro, Valeria oth Arturi, Franco oth Bolignano, Davide oth Russo, Emilio oth De Sarro, Giovambattista oth Andreucci, Michele oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:129 year:2018 pages:274-294 extent:21 https://doi.org/10.1016/j.phrs.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 129 2018 274-294 21 045F 610 |
allfields_unstemmed |
10.1016/j.phrs.2017.12.001 doi GBV00000000000144A.pica (DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Coppolino, Giuseppe verfasserin aut Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 2018 21 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier Leporini, Christian oth Rivoli, Laura oth Ursini, Francesco oth di Paola, Eugenio Donato oth Cernaro, Valeria oth Arturi, Franco oth Bolignano, Davide oth Russo, Emilio oth De Sarro, Giovambattista oth Andreucci, Michele oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:129 year:2018 pages:274-294 extent:21 https://doi.org/10.1016/j.phrs.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 129 2018 274-294 21 045F 610 |
allfieldsGer |
10.1016/j.phrs.2017.12.001 doi GBV00000000000144A.pica (DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Coppolino, Giuseppe verfasserin aut Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 2018 21 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier Leporini, Christian oth Rivoli, Laura oth Ursini, Francesco oth di Paola, Eugenio Donato oth Cernaro, Valeria oth Arturi, Franco oth Bolignano, Davide oth Russo, Emilio oth De Sarro, Giovambattista oth Andreucci, Michele oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:129 year:2018 pages:274-294 extent:21 https://doi.org/10.1016/j.phrs.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 129 2018 274-294 21 045F 610 |
allfieldsSound |
10.1016/j.phrs.2017.12.001 doi GBV00000000000144A.pica (DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Coppolino, Giuseppe verfasserin aut Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 2018 21 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier Leporini, Christian oth Rivoli, Laura oth Ursini, Francesco oth di Paola, Eugenio Donato oth Cernaro, Valeria oth Arturi, Franco oth Bolignano, Davide oth Russo, Emilio oth De Sarro, Giovambattista oth Andreucci, Michele oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:129 year:2018 pages:274-294 extent:21 https://doi.org/10.1016/j.phrs.2017.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 129 2018 274-294 21 045F 610 |
language |
English |
source |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:129 year:2018 pages:274-294 extent:21 |
sourceStr |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:129 year:2018 pages:274-294 extent:21 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Alogliptin (PubChem CID: 11450633) Linagliptin (PubChem CID: 10096344) Sitagliptin (PubChem CID: 4369359) Saxagliptin (PubChem CID: 11243969) Glucagon-like peptide-1 (PubChem CID: 16135499) Vildagliptin (PubChem CID: 6918537) |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
authorswithroles_txt_mv |
Coppolino, Giuseppe @@aut@@ Leporini, Christian @@oth@@ Rivoli, Laura @@oth@@ Ursini, Francesco @@oth@@ di Paola, Eugenio Donato @@oth@@ Cernaro, Valeria @@oth@@ Arturi, Franco @@oth@@ Bolignano, Davide @@oth@@ Russo, Emilio @@oth@@ De Sarro, Giovambattista @@oth@@ Andreucci, Michele @@oth@@ |
publishDateDaySort_date |
2018-01-01T00:00:00Z |
hierarchy_top_id |
ELV008224951 |
dewey-sort |
3610 |
id |
ELV042066786 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV042066786</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624093500.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2017.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000144A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV042066786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(17)30860-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coppolino, Giuseppe</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">21</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alogliptin (PubChem CID: 11450633)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Linagliptin (PubChem CID: 10096344)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sitagliptin (PubChem CID: 4369359)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Saxagliptin (PubChem CID: 11243969)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glucagon-like peptide-1 (PubChem CID: 16135499)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vildagliptin (PubChem CID: 6918537)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leporini, Christian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rivoli, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ursini, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">di Paola, Eugenio Donato</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cernaro, Valeria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arturi, Franco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bolignano, Davide</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Russo, Emilio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Sarro, Giovambattista</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andreucci, Michele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:129</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:274-294</subfield><subfield code="g">extent:21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2017.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">129</subfield><subfield code="j">2018</subfield><subfield code="h">274-294</subfield><subfield code="g">21</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Coppolino, Giuseppe |
spellingShingle |
Coppolino, Giuseppe ddc 610 ddc 330 Elsevier Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
authorStr |
Coppolino, Giuseppe |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008224951 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 330 - Economics |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 330 VZ Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) Elsevier |
topic |
ddc 610 ddc 330 Elsevier Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) |
topic_unstemmed |
ddc 610 ddc 330 Elsevier Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) |
topic_browse |
ddc 610 ddc 330 Elsevier Alogliptin (PubChem CID: 11450633) Elsevier Linagliptin (PubChem CID: 10096344) Elsevier Sitagliptin (PubChem CID: 4369359) Elsevier Saxagliptin (PubChem CID: 11243969) Elsevier Glucagon-like peptide-1 (PubChem CID: 16135499) Elsevier Vildagliptin (PubChem CID: 6918537) |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
c l cl l r lr f u fu p e d d ped pedd v c vc f a fa d b db e r er s g d sg sgd m a ma |
hierarchy_parent_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
hierarchy_parent_id |
ELV008224951 |
dewey-tens |
610 - Medicine & health 330 - Economics |
hierarchy_top_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV008224951 |
title |
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
ctrlnum |
(DE-627)ELV042066786 (ELSEVIER)S1043-6618(17)30860-5 |
title_full |
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
author_sort |
Coppolino, Giuseppe |
journal |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
journalStr |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology 300 - Social sciences |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
zzz |
container_start_page |
274 |
author_browse |
Coppolino, Giuseppe |
container_volume |
129 |
physical |
21 |
class |
610 610 DE-600 330 VZ |
format_se |
Elektronische Aufsätze |
author-letter |
Coppolino, Giuseppe |
doi_str_mv |
10.1016/j.phrs.2017.12.001 |
dewey-full |
610 330 |
title_sort |
exploring the effects of dpp-4 inhibitors on the kidney from the bench to clinical trials |
title_auth |
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
abstract |
Display Omitted |
abstractGer |
Display Omitted |
abstract_unstemmed |
Display Omitted |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
title_short |
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials |
url |
https://doi.org/10.1016/j.phrs.2017.12.001 |
remote_bool |
true |
author2 |
Leporini, Christian Rivoli, Laura Ursini, Francesco di Paola, Eugenio Donato Cernaro, Valeria Arturi, Franco Bolignano, Davide Russo, Emilio De Sarro, Giovambattista Andreucci, Michele |
author2Str |
Leporini, Christian Rivoli, Laura Ursini, Francesco di Paola, Eugenio Donato Cernaro, Valeria Arturi, Franco Bolignano, Davide Russo, Emilio De Sarro, Giovambattista Andreucci, Michele |
ppnlink |
ELV008224951 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.phrs.2017.12.001 |
up_date |
2024-07-06T21:48:50.334Z |
_version_ |
1803867946048552960 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV042066786</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624093500.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2017.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000144A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV042066786</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(17)30860-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coppolino, Giuseppe</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">21</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alogliptin (PubChem CID: 11450633)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Linagliptin (PubChem CID: 10096344)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Sitagliptin (PubChem CID: 4369359)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Saxagliptin (PubChem CID: 11243969)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Glucagon-like peptide-1 (PubChem CID: 16135499)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Vildagliptin (PubChem CID: 6918537)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Leporini, Christian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rivoli, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ursini, Francesco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">di Paola, Eugenio Donato</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cernaro, Valeria</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arturi, Franco</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bolignano, Davide</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Russo, Emilio</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">De Sarro, Giovambattista</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andreucci, Michele</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:129</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:274-294</subfield><subfield code="g">extent:21</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2017.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">129</subfield><subfield code="j">2018</subfield><subfield code="h">274-294</subfield><subfield code="g">21</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.399374 |